Lectil

Betahistine Dihydrochloride, the active ingredient in Lectil, is a histamine analog that acts as an H1 receptor agonist and H3 antagonist, presented as an oral tablet for oral use. It is employed to alleviate vertigo, Meniere’s disease and other balance disorders in adult patients.

GNH USA supplies Lectil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across all markets. The company maintains robust cold‑chain logistics where required and provides full documentation for import and customs clearance.

Lectil (betahistine) works on the vestibular apparatus by enhancing histamine turnover and inner‑ear blood flow, and it is formally indicated for the following clinically recognised conditions.

Vertigo: Reduces the frequency and intensity of spinning sensations in patients with vestibular dysfunction. Meniere's disease: Helps control episodic vertigo and associated hearing fluctuations. Balance disorders: Improves postural stability in individuals with chronic disequilibrium.

Betahistine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate headache reported. - Nausea: occasional gastrointestinal upset. - Indigestion: dyspeptic symptoms such as heartburn. - Transient flushing: brief skin redness.

Serious or Rare Side Effects: - Allergic reaction: rash, pruritus, or angioedema requiring medical attention. - Severe hypotension: marked drop in blood pressure, especially when combined with other vasodilators. - Cardiac arrhythmia: rare reports of irregular heartbeat.

When prescribing betahistine, clinicians should consider the following precautions to ensure safe use.

Renal impairment: adjust use in patients with severe kidney dysfunction. Cardiovascular disease: monitor blood pressure in individuals with known hypotension. Concomitant antihistamines: avoid combining with strong H1 antagonists that may counteract effect. Pregnancy and lactation: use only if potential benefit outweighs risk, as data are limited. Elderly patients: start at lower dose and monitor for adverse effects. Store at ambient temperature: keep tablets in original packaging, protect from moisture and direct sunlight.

Betahistine may interact with other medicines; the following interactions are noteworthy.

Major Interactions (Avoid): - Strong vasodilators (e.g., nitroglycerin): may cause additive hypotensive effect. - Monoamine oxidase inhibitors (MAOIs): risk of excessive histamine activity. - Antihistamines (first‑generation H1 blockers): may diminish therapeutic benefit.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: monitor blood pressure for additive lowering. - CYP450 substrates: betahistine is minimally metabolized, but monitor for unexpected changes. - Diuretics: watch for electrolyte disturbances.